Addex Therapeutics Ltd (ADXN) Reports In-Line Q3 EPS

Addex Therapeutics Ltd (NASDAQ: ADXN) reported Q3 EPS of ($0.09), in-line with the analyst estimate of ($0.09). Revenue for the quarter came in at $420 thousand versus the consensus estimate of $426.71 thousand.

For earnings history and earnings-related data on Addex Therapeutics Ltd (ADXN) click here.

You May Also Be Interested In

• L3Harris CEO steps down amid conduct review, shares drop
• Citius Pharmaceuticals (CTXR) Misses Q3 EPS by 37c
• InspireMD (NSPR) Tops Q2 EPS by 1c